Brimonidine is a selective alpha-2 adrenergic agonist primarily used to treat open-angle glaucoma and ocular hypertension by lowering intraocular pressure. Within pharmaceutical development and quality… Read more


![Chemical structure of (Z)-1-(5-Bromoquinoxalin-6-yl)-3-hydroxy-8,9-dihydro-1H-imidazo[2,1-c][1,2,4]oxadiazocin-6(5H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FZ-1-5-Bromoquinoxalin-6-yl-3-hydroxy-89-dihydro-1H-imidazo21-c124oxadiazocin-65H-one.png&w=3840&q=75)






![Chemical structure of 1-(5-Bromoquinoxalin-6-yl)-2,3-dihydro-1H-imidazo[1,2-a]imidazol-3-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-5-Bromoquinoxalin-6-yl-23-dihydro-1H-imidazo12-aimidazol-3-ol.png&w=3840&q=75)
![Chemical structure of 1-(5-Bromoquinoxalin-6-yl)-3-hydroxy-5,6-dihydro-1H-imidazo[1,2-a]imidazol-2(3H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-5-Bromoquinoxalin-6-yl-3-hydroxy-56-dihydro-1H-imidazo12-aimidazol-23H-one.png&w=3840&q=75)



















![Chemical structure of 8-((5-Bromoquinoxalin-6-yl)imino)-1,5-diazabicyclo[3.2.1]octan-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F8-5-Bromoquinoxalin-6-ylimino-15-diazabicyclo3.2.1octan-2-one.png&w=3840&q=75)
![Chemical structure of 8-(5-Bromo-6-quinoxalinyl)-2,3,5,6,7,8-hexahydro-5-oxoimidazo[1,2-a]pyrimidine-7-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F934548-66-0-8-5-Bromo-6-quinoxalinyl-235678-hexahydro-5-oxoimidazo12-apyrimidine-7-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of 8-(5-Bromo-6-quinoxalinyl)-2,3,5,6,7,8-hexahydro-5-oxoimidazo[1,2-a]pyrimidine-7-carboxylic Acid Lithium Salt](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F8-5-Bromo-6-quinoxalinyl-235678-hexahydro-5-oxoimidazo12-apyrimidine-7-carboxylic-Acid-Lithium-Salt.png&w=3840&q=75)
![Chemical structure of 8-(5-Bromoquinoxalin-6-yl)-7-oxo-2,3,5,6,7,8-hexahydroimidazo[1,2-a]pyrimidine-5-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F8-5-Bromoquinoxalin-6-yl-7-oxo-235678-hexahydroimidazo12-apyrimidine-5-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of 8-(8-Bromoquinoxalin-6-yl)hexahydroimidazo[1,2-a]pyrimidin-6(5H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F8-8-Bromoquinoxalin-6-ylhexahydroimidazo12-apyrimidin-65H-one.png&w=3840&q=75)

![Chemical structure of 9,10-Dihydro-7H-imidazo[1',2':1,2]imidazo[4,5-c][1,5]naphthyridine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F949916-82-9-910-Dihydro-7H-imidazo1212imidazo45-c15naphthyridine.png&w=3840&q=75)
![Chemical structure of 9,10-Dihydro-7H-imidazo[2',1':2,3]imidazo[4,5-f]quinoxaline](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F910-Dihydro-7H-imidazo2123imidazo45-fquinoxaline.png&w=3840&q=75)
![Chemical structure of 9-(5-Bromoquinoxalin-6-yl)-6,7-dihydroxy-2,6,7,9-tetrahydro-3H-imidazo[1,2-a][1,3]diazepine-5,8-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F9-5-Bromoquinoxalin-6-yl-67-dihydroxy-2679-tetrahydro-3H-imidazo12-a13diazepine-58-dione.png&w=3840&q=75)











Brimonidine is a selective alpha-2 adrenergic agonist primarily used to treat open-angle glaucoma and ocular hypertension by lowering intraocular pressure. Within pharmaceutical development and quality control, reference standards of Brimonidine, along with its associated pharmacopeial and non-pharmacopeial impurities, are essential for maintaining regulatory compliance. These compounds enable accurate impurity profiling, allowing for the precise identification and quantification of degradation products and synthetic intermediates during batch release testing. Furthermore, stable isotope-labelled versions of the drug serve as critical internal standards for highly sensitive quantitative bioanalysis and mass spectrometry applications. Laboratories utilize these validated reference materials to support robust analytical method development and stability studies, ensuring that pharmaceutical formulations meet safety and efficacy standards throughout the entire product lifecycle.